
In this series, Dr. Kim-Tenser, MD, a leading neurologist, explores the evolving landscape of acute ischemic stroke treatment. She examines how treatment strategies have progressed over time, from early interventions to the latest breakthroughs in reperfusion therapy. Dr. Kim-Tenser also discusses the most recent advances in stroke care, including novel thrombolytic agents and cutting-edge procedural techniques, and their impact on patient outcomes. Additionally, she emphasizes the importance of staying informed on emerging therapies, ensuring clinicians are equipped with the latest knowledge to optimize stroke management now and in the future.
- Dx Dialogues: The historical approach to treating acute ischemic strokes
- Dx Dialogues: New treatment advances for acute ischemic strokes
- Dx Dialogues: The importance of staying up to date with AIS treatments
Featured Content
Article
Refining stroke thrombolysis: the role of tenecteplase in modern ais treatmentOptimizing dosing and expanding access to timely reperfusion
Article
Tenecteplase in acute ischemic stroke: a new era in thrombolysisComparing thrombolytic options for efficient stroke management
Article
Bridging the stroke treatment gap: addressing disparities in access to acute therapiesOvercoming barriers to equitable stroke care
Article
Expanding rural stroke care with tenecteplase: a step toward equitable accessLeveraging simpler thrombolysis to overcome geographic barriers